Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis

MLA

Irina Elovaara, et al. Multicentre, Randomised, Double Blind, Placebo Controlled, Phase III Study of Weekly, Low Dose, Subcutaneous Interferon Beta-1a in Secondary Progressive Multiple Sclerosis. Jan. 2004. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....148d2560c569aac42cf940b358f5ba3b&authtype=sso&custid=ns315887.

APA

Irina Elovaara, K-M Myhr, H J Hansen, Markus Färkkilä, Magnhild Sandberg-Wollheim, P. Soelberg Sørensen, Oluf Andersen, & Svein Ivar Mellgren. (2004). Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis.

Chicago

Irina Elovaara, K-M Myhr, H J Hansen, Markus Färkkilä, Magnhild Sandberg-Wollheim, P. Soelberg Sørensen, Oluf Andersen, and Svein Ivar Mellgren. 2004. “Multicentre, Randomised, Double Blind, Placebo Controlled, Phase III Study of Weekly, Low Dose, Subcutaneous Interferon Beta-1a in Secondary Progressive Multiple Sclerosis,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....148d2560c569aac42cf940b358f5ba3b&authtype=sso&custid=ns315887.